Hematologic Malignancies and Stem Cell Biology Research

Investigators in the hematologic malignancies and stem cell biology research group focus on comparing molecular and cellular regulation of stem and progenitor cell populations in hematopoietic, endothelial and mesenchymal lineages using studies performed in human, murine and other species. Stem cell biology in the context of development, homeostasis and leukemic transformation is examined to understand the genetic basis for normal lineage specification and maintenance.

Meet the Hematologic Malignancies and Stem Cell Biology group

8 Principal Investigators

1 million annually in research funds

5 Trainees

Cooperative Center of Excellence in Hematology

The Indiana University School of Medicine Cooperative Center of Excellence in Hematology (IU-CCEH), funded by the National Institute of Diabetes and Digestive and Kidney Diseases, brings together investigators whose research activities are focused on various aspects of nonmalignant hematology. The center supports three biomedical research cores that are essential to these investigators' research efforts. The center also sponsors a robust enrichment program to advance the development of students and early career members.

Learn more about IU-CCEH

Research News

Deutsch Research Scholarship recipient seeks cancer treatments as unique as each patient

^{Cindy Dashnaw | Dec. 13, 2022}

Where the science leads: Newly named AAAS Fellows share adventures in scientific discovery

First Postgraduate Medical Education by Telephone in State and Nation presented by IU School of Medicine and Indiana State Medical Association in 1950

Fasting flips a switch and the liver holds the key

IU's Rare Disease Clinic solves 10-year medical mystery for Indianapolis girl with unknown neurodevelopmental disorder

Barth syndrome breakthrough: Rare disease research fueled by determined family and scientists